Literature DB >> 6861376

Radioimmunoassay for antibodies to human skeletal muscle myosin in serum from patients with polymyositis.

K Wada, S Ueno, T Hazama, S Ogasahara, J Kang, M Takahashi, S Tarui.   

Abstract

Antibodies to human skeletal muscle myosin were detected in 90% of sera from patients with polymyositis by radioimmunoassay using purified human myosin as antigen, and the mean titre was 4.24 X 10(-10)M. The incidence and the mean titre of anti-myosin antibodies were significantly higher than in patients without polymyositis. Anti-myosin antibody titres correlated with steroid therapy in polymyositis patients. Titres in untreated patients with polymyositis correlated with the severity of muscle weakness. Radioimmunoassay for anti-myosin antibodies should prove to be useful in the diagnosis of polymyositis and the evaluation of clinical state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861376      PMCID: PMC1535834     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Polypeptide chains of intermediate molecular weight in myosin preparations.

Authors:  R Starr; G Offer
Journal:  FEBS Lett       Date:  1971-06-02       Impact factor: 4.124

2.  Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis.

Authors:  R P Lisak; B Zweiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

3.  Chromatography of myosin on diethylaminoethyl-Sephadex A-50.

Authors:  E G Richards; C S Chung; D B Menzel; H S Olcott
Journal:  Biochemistry       Date:  1967-02       Impact factor: 3.162

4.  Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression.

Authors:  R L Dawkins; F L Mastaglia
Journal:  N Engl J Med       Date:  1973-03-01       Impact factor: 91.245

5.  Circulating antibodies in polymyositis.

Authors:  G M Stern; A L Rose; K Jacobs
Journal:  J Neurol Sci       Date:  1967 Jul-Aug       Impact factor: 3.181

6.  Autoimmunity in the pathogenesis of muscle disease.

Authors:  W J Fessel; M C Raas
Journal:  Neurology       Date:  1968-11       Impact factor: 9.910

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Myosin polymorphism in human skeletal muscles.

Authors:  L D Libera; A Margreth; I Mussini; C Cerri; G Scarlato
Journal:  Muscle Nerve       Date:  1978 Jul-Aug       Impact factor: 3.217

9.  Myosin light chains in Duchenne dystrophy and paraplegic muscle.

Authors:  F J Samaha; W H Thies
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

10.  Circulating autoantibody against human myoglobin in polymyositis.

Authors:  M Nishikai; M Homma
Journal:  JAMA       Date:  1977-04-25       Impact factor: 56.272

View more
  7 in total

1.  Lack of natural antibodies in rheumatic diseases.

Authors:  J W Bijlsma; C Plater-Zyberk; P Mumford; R N Maini
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 2.  Polymyositis-dermatomyositis: a clinical review.

Authors:  K W Strauss; H Gonzalez-Buritica; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

3.  Detection of anti-contractile antibodies after cardiac surgery using ELISA assay.

Authors:  I De Scheerder; J Vandekerckhove; G De Schrijver; M Hoste; D Clement; R Wieme; R Pannier
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

4.  Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases.

Authors:  C A von Mühlen; E K Chan; C L Peebles; H Imai; K Kiyosawa; E M Tan
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 5.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

6.  Clinical, biochemical and histological responses to treatment in polymyositis: a prospective study.

Authors:  R J Lane; A Emslie-Smith; I E Mosquera; P Hudgson
Journal:  J R Soc Med       Date:  1989-06       Impact factor: 18.000

7.  Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu.

Authors:  Nicholas A Young; Rahul Sharma; Alexandra K Friedman; Benjamin H Kaffenberger; Brad Bolon; Wael N Jarjour
Journal:  Arthritis Rheum       Date:  2013-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.